CEL SCI CORP (CVM) IPO - S-1 Filing, Stock & Insider Activity
CEL SCI CORP IPO - Status & S-1 Filing
- Ticker: CVM
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-04-17
- Exchange: NYSE
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 4,885,993
- SEC CIK: 0000725363 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
CEL SCI CORP (CVM) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. Insiders disclosed 2 open-market purchases totaling $479K. 3 Form 8-K material event filings were reported by CVM in the last 90 days. InsiderAlpha tracks every CVM SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About CEL SCI CORP (CVM)
CEL SCI CORP trades under the ticker CVM. InsiderAlpha tracks 30 primary SEC Form 4 filings from 6 reporting insiders for CVM since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Biological Products, (No Diagnostic Substances) (SIC 2836) |
| SEC CIK | 0000725363 |
90-Day SEC Filing Activity
| Insider purchases (90d) | 2 ($479K) |
|---|---|
| Form 4 filings (90d) | 5 |
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-07-01 |
Recent CVM Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Geert R. Kersten | Chief Executive Officer | A - Grant or award | 5.2K | $1.04 | $5K | SEC | |
| Eyal Talor | Chief Scientific Officer | A - Grant or award | 2.3K | $1.04 | $2K | SEC | |
| Patricia B. Prichep | Chief Financial Officer | A - Grant or award | 4.1K | $1.04 | $4K | SEC | |
| Geert R. Kersten | Chief Executive Officer | P - Open-market purchase | 300.0K | $1.20 | $360K | SEC | |
| Geert R. Kersten | Chief Executive Officer | P - Open-market purchase | 100.0K | $1.19 | $119K | SEC | |
| Eyal Talor | Chief Scientific Officer | A - Grant or award | 747 | $3.21 | $2K | SEC | |
| Geert R. Kersten | Chief Executive Officer | A - Grant or award | 1.7K | $3.21 | $5K | SEC | |
| Patricia B. Prichep | Chief Financial Officer | A - Grant or award | 1.3K | $3.21 | $4K | SEC | |
| Geert R. Kersten | Chief Executive Officer | P - Open-market purchase | 38.0K | $5.26 | $200K | SEC | |
| Geert R. Kersten | Chief Executive Officer | P - Open-market purchase | 8.4K | $5.96 | $50K | SEC | |
| Geert R. Kersten | Chief Executive Officer | A - Grant or award | 570 | $9.20 | $5K | SEC | |
| Eyal Talor | Chief Scientific Officer | A - Grant or award | 260 | $9.20 | $2K | SEC | |
| Patricia B. Prichep | Chief Financial Officer | A - Grant or award | 466 | $9.20 | $4K | SEC | |
| Robert Eugene Watson | Director | P - Open-market purchase | 2.9K | $6.85 | $20K | SEC | |
| Geert R. Kersten | Chief Executive Officer | P - Open-market purchase | 29.2K | $6.85 | $200K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for CEL SCI CORP (CVM). Updated in real time as new filings are submitted to the SEC.
Most-Active CVM Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Geert R. Kersten | 3 | $484K |
| Patricia B. Prichep | 1 | $4K |
| Eyal Talor | 1 | $2K |
Recent CVM Form 8-K Material Events
Recent Insider Filings
- - Eyal Talor (Chief Scientific Officer)
- - Patricia B. Prichep (Chief Financial Officer)
- - Geert R. Kersten (Chief Executive Officer)
- - Geert R. Kersten (Chief Executive Officer)
- - Geert R. Kersten (Chief Executive Officer)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CVM insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
CVM Insider Trading - FAQ
- What is the latest insider trade for CVM?
- CEL SCI CORP (CVM) had 5 insider filings in the last 90 days, with the most recent on 2026-07-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying CVM stock?
- 2 insider purchases of CVM were filed in the last 90 days, totaling $479K.
- How many insiders are selling CVM stock?
- 0 insider sales of CVM were filed in the last 90 days.
- Where can I see CVM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks CVM Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $DMAC DiaMedica Therapeutics Inc.
- $EDGM Edgemode, Inc.
- $ERNA Ernexa Therapeutics Inc.
- $ETNB 89bio, Inc.
- $EWTX Edgewise Therapeutics, Inc.
- $FBIO Fortress Biotech, Inc.
- $GNPX Genprex, Inc.
- $GOVX GeoVax Labs, Inc.
- $GRI GRI Bio, Inc.
- $GRML Greenland Mines Ltd
Related Companies - Recent Insider Activity
- AMGEN INC (AMGN)
- NEUROCRINE BIOSCIENCES INC (NBIX)
- Twist Bioscience Corp (TWST)
- Kymera Therapeutics, Inc. (KYMR)
- EXELIXIS, INC. (EXEL)
- Moderna, Inc. (MRNA)
- RECURSION PHARMACEUTICALS, INC. (RXRX)
- BioCardia, Inc. (BCDA)
- Maze Therapeutics, Inc. (MAZE)
- MeiraGTx Holdings plc (MGTX)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live CVM dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.